Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study.

Gray TR, LaGasse LL, Smith LM, Derauf C, Grant P, Shah R, Arria AM, Della Grotta SA, Strauss A, Haning WF, Lester BM, Huestis MA. Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study. Ther Drug Monit. 2009 Dec; 31(6):769-75.

View in: PubMed

subject areas

Adolescent
Adult
Amphetamines
Cannabinoids
Cotinine
Female
Humans
Infant, Newborn
Interviews as Topic
Male
Marijuana Smoking
Maternal Exposure
Meconium
Neurotoxins
Pregnancy
Pregnancy Trimesters
Self Disclosure
Sensitivity and Specificity
Smoking
Substance Abuse Detection
Young Adult

authors with profiles

William Haning, MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support